The Supreme Court has intervened to keep abortion pills accessible by mail, issuing a stay that halts a lower court's attempt to impose in-person requirements for obtaining mifepristone.
This emergency order ensures that the current FDA policy—which allows these drugs to be distributed via telemedicine and mail—remains in effect while the underlying lawsuit, initiated by the state of Louisiana, works its way through the judicial system.
Louisiana has rightly argued that the federal government’s push to mail these drugs nationwide directly undermines the state’s own laws protecting unborn life and its policy recognizing the humanity of the unborn from conception. An appeals court had previously sided with Louisiana, noting that the FDA’s actions effectively nullify state-level bans.
However, the Supreme Court’s latest move keeps the status quo in place, with Justices Clarence Thomas and Samuel Alito dissenting.
Justice Thomas was particularly pointed in his dissent, noting that because the mailing of these drugs is illegal in Louisiana, the manufacturers should not be permitted to use the courts to protect the profits of what he characterized as a criminal enterprise.
As the legal fight continues toward a potential hearing next year, the debate remains centered on whether federal agencies can override state sovereignty and the moral protections states have enacted for the unborn.
Tags
